Market Overview

UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on Rite Aid Corporation

Share:
Related RAD
What Wall Street Thinks Of The $69 Billion CVS-Aetna Deal
With Rite Aid Uncertainty Behind It, Could Walgreens Go Shopping?
Stocks to watch next week (Seeking Alpha)

In a report published Friday, Goldman Sachs Group reiterated its Neutral rating on Rite Aid Corporation (NYSE: RAD), and slightly raised its price target from $1.35 to $1.50.

Goldman Sachs noted, “Because RAD operates with enormous operating and financial leverage, a modest change in margins can deliver an outsized impact to its share price. The current surge in generic profitability is aiding the entire sector, but delivering the biggest benefits to RAD, as 3Q12 results beat forecasts on a spike in gross profit led by generics. We believe these developments are enabling a higher level of investment in stores and service, bringing RAD closer to a virtuous cycle that would enable it to upgrade its operations and pave a path to sustained profitability. Our confidence in this scenario is mitigated by our view that some factors driving accelerating earnings growth are peaking, including the impact of generics on margin and earnings growth from scripts gained during WAG's impasse with ESRX.”

Rite Aid Corporation closed on Thursday at $1.21.

Latest Ratings for RAD

DateFirmActionFromTo
Dec 2017Deutsche BankInitiates Coverage OnHold
Sep 2017Loop CapitalMaintainsHold
Sep 2017RBC CapitalInitiates Coverage OnSector Perform

View More Analyst Ratings for RAD
View the Latest Analyst Ratings

Posted-In: Goldman Sachs GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (RAD)

View Comments and Join the Discussion!